A Four-Part Study to Evaluate the Safety, Tolerability and Pharmacodynamic Effects of PUR118 and Placebo in Normal Healthy Volunteers and Subjects With COPD.

Trial Profile

A Four-Part Study to Evaluate the Safety, Tolerability and Pharmacodynamic Effects of PUR118 and Placebo in Normal Healthy Volunteers and Subjects With COPD.

Completed
Phase of Trial: Phase I

Latest Information Update: 06 Sep 2012

At a glance

  • Drugs PUR 118 (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Adverse reactions; Biomarker
  • Most Recent Events

    • 04 Sep 2012 Results were presented at the 22nd Annual Congress of the European Respiratory Society (ERS-2012).
    • 04 Sep 2012 Status changed from recruiting to completed.
    • 21 Nov 2011 Planned Eed date changed from 1 Aug 2011 to 1 Jan 2012 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top